TOK-8801
TOK-8801 is a synthesized dihydroimidazothiazole carboxamide and is under development as an immunomodulator.
Product Specifications
CAS Number
105963-46-0
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/TOK-8801.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(C)N2C(S1)=NC(C)(C)C2)NCCC3=CC=CC=C3
Molecular Formula
C17H21N3OS
Molecular Weight
315.43
References & Citations
[1]Fujiwara M, et al. Immunomodulatory activity of the newly synthesized compound TOK-8801 (N- (2-phenylethyl) -3,6,6-trimethyl-5,6-dihydroimidazo[2,1-b]thiazole-2- carboxamide) . Jpn J Pharmacol. 1989 Dec;51 (4) :549-54.|[2]Shibata K, et al. Immunomodulatory effect of a newly synthesized compound, TOK-8801 (N- (2-phenylethyl) -3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type hypersensitivity in mice. Int J Immunopharmacol. 1990;12 (5) :497-502.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AS16 3527 0.5 mg
Goat anti-Rabbit IgG (H&L), F (ab) '2 Fragment, DyLight® 488 conjugated
Sign In for Pricing
View Details